Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

BUY
$0.42 - $0.72 $1,378 - $2,363
3,282 Added 11.54%
31,713 $19,000
Q3 2023

Nov 02, 2023

SELL
$0.6 - $1.53 $1,301 - $3,318
-2,169 Reduced 7.09%
28,431 $17,000
Q2 2023

Aug 07, 2023

BUY
$1.05 - $1.63 $2,867 - $4,451
2,731 Added 9.8%
30,600 $34,000
Q1 2023

May 09, 2023

BUY
$1.2 - $2.73 $15,044 - $34,226
12,537 Added 81.77%
27,869 $37,000
Q4 2022

Feb 09, 2023

SELL
$1.71 - $3.61 $59,932 - $126,523
-35,048 Reduced 69.57%
15,332 $28,000
Q3 2022

Nov 09, 2022

BUY
$1.9 - $8.63 $24,190 - $109,877
12,732 Added 33.82%
50,380 $124,000
Q2 2022

Aug 10, 2022

SELL
$2.13 - $9.01 $19,214 - $81,279
-9,021 Reduced 19.33%
37,648 $92,000
Q1 2022

May 09, 2022

SELL
$6.28 - $15.59 $5,620 - $13,953
-895 Reduced 1.88%
46,669 $372,000
Q4 2021

Feb 09, 2022

SELL
$14.7 - $28.67 $228,099 - $444,872
-15,517 Reduced 24.6%
47,564 $726,000
Q3 2021

Nov 09, 2021

SELL
$24.31 - $33.6 $203,620 - $281,433
-8,376 Reduced 11.72%
63,081 $1.79 Million
Q2 2021

Aug 10, 2021

BUY
$26.09 - $40.4 $416,631 - $645,147
15,969 Added 28.78%
71,457 $2.41 Million
Q1 2021

May 10, 2021

SELL
$33.06 - $56.93 $42,911 - $73,895
-1,298 Reduced 2.29%
55,488 $2.12 Million
Q4 2020

Feb 08, 2021

BUY
$39.09 - $57.4 $740,130 - $1.09 Million
18,934 Added 50.02%
56,786 $2.37 Million
Q3 2020

Nov 06, 2020

SELL
$28.43 - $44.67 $64,450 - $101,266
-2,267 Reduced 5.65%
37,852 $1.64 Million
Q2 2020

Aug 05, 2020

SELL
$11.71 - $30.29 $1.13 Million - $2.92 Million
-96,505 Reduced 70.64%
40,119 $1.22 Million
Q1 2020

May 12, 2020

BUY
$7.64 - $27.5 $6,516 - $23,457
853 Added 0.63%
136,624 $1.87 Million
Q4 2019

Feb 05, 2020

BUY
$15.02 - $20.57 $1.18 Million - $1.62 Million
78,598 Added 137.47%
135,771 $2.19 Million
Q3 2019

Nov 13, 2019

BUY
$18.85 - $27.5 $93,816 - $136,867
4,977 Added 9.54%
57,173 $1.1 Million
Q2 2019

Aug 12, 2019

BUY
$17.37 - $26.27 $227,390 - $343,900
13,091 Added 33.48%
52,196 $1.23 Million
Q1 2019

May 10, 2019

BUY
$10.65 - $25.75 $101,100 - $244,444
9,493 Added 32.06%
39,105 $916,000
Q4 2018

Feb 14, 2019

BUY
$9.26 - $16.38 $163,679 - $289,532
17,676 Added 148.09%
29,612 $328,000
Q3 2018

Nov 14, 2018

BUY
$7.54 - $18.31 $89,997 - $218,548
11,936 New
11,936 $200,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.